Lazard Capital Starts Kythera Biopharmaceuticals (KYTH) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Goldman Sachs Starts Kythera Biopharmaceuticals (KYTH) at Neutral
November 5, 2012 9:11 AM ESTGoldman Sachs initiates coverage on Kythera Biopharmaceuticals (NASDAQ: KYTH) with a Neutral. PT $23.00.
The analyst comments: "Kythera's story is driven by ATX-101, a first-in-class injectable product for localized fat reduction that we believe holds both a high likelihood of achieving FDA approval and... More
Leerink Swann Starts Kythera Biopharmaceuticals (KYTH) at Outperform; Next Big Think in Facial Aesthetics
November 5, 2012 8:48 AM ESTLeerink Swann initiates coverage on Kythera Biopharmaceuticals (NASDAQ: KYTH) with a Outperform. PT $28.00.
The firm comments: "We recommend purchase of KYTH based on (1) compelling prospects for clinical and regulatory success in the US and Europe for a first-inclass product (ATX-101) for the treatment of... More
JPMorgan Starts Kythera Biopharmaceuticals (KYTH) at Overweight
November 5, 2012 8:44 AM ESTJPMorgan initiates coverage on Kythera Biopharmaceuticals (NASDAQ: KYTH) with a Overweight. PT $30.00.
For an analyst ratings summary and ratings history on Kythera Biopharmaceuticals click here. For more ratings news on Kythera Biopharmaceuticals click here.
Shares of Kythera Biopharmaceuticals closed at $22.11 yesterday, with a 52 week range of $18.49-$25.30.... More
